{"url_path":"/sec/feed/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1326706/0001493152-26-024191-index.html","accession_number":"0001493152-26-024191","cik":"0001326706","ticker":"FEED","issuer_name":"ENvue Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1326706/0001493152-26-024191-index.html","primary_entity_key":"0001326706","primary_entity_name":"ENvue Medical, Inc."},"word_count":151,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nFrom\ntime to time, we may be involved in certain claims and litigation arising out of the ordinary course and conduct of business. Management\nassesses such claims and, if it considers that it is probable that an asset had been impaired or a liability had been incurred and the\namount of loss can be reasonably estimated, provisions for loss are made based on management’s assessment of the most likely outcome.\n\n \n\nThe\ninformation set forth in Note 13 – Commitments and Contingencies of the Notes to Interim Condensed Consolidated Financial\nStatements of this Quarterly Report is incorporated by reference herein.\n\n \n\nThere\nare no other material proceedings in which any of our directors, officers, affiliates, any registered or beneficial stockholder of more\nthan 5% of our common stock, or any associate of any of the foregoing is an adverse party or has a material interest adverse to our interest."}